Myotubular Myopathy (Discovered in the Rottweiler)
Myotubular Myopathy (Discovered in the Rottweiler). X-linked recessive. Observed in 0 of 266 breeds tested in the Sniff Atlas, with measured variant frequencies drawn from 242,662 dogs (Donner 2023). Whether a dog carrying this variant is at risk depends on the disease’s inheritance pattern; outcome also depends on penetrance, modifiers, and environment. The frequencies below describe variant prevalence, not confirmed disease incidence.
- OMIA identifier
- OMIA:001508-9615
- InheritanceInheritance patternWhat it isHow the condition is passed down: recessive (two copies needed), dominant (one copy), or more complex.For your dogRecessive means a single-copy carrier is usually healthy but can still pass it on.PreciselyThe documented mode of Mendelian transmission (autosomal recessive or dominant, X-linked, etc.) per OMIA.OMIA · documented
- X-linked recessive
- Linked gene
- MTM1
- Human counterpart
- In humans, this gene is MTM1. OMIM 300415 In people, variants in the MTM1 gene are classified as pathogenic in ClinVar for 2 expert-reviewed conditions.
- Source dataset
- Sniff Atlas v1.0.1 / DOI
A model of human X-linked myotubular myopathy
Dogs with this condition carry a change in MTM1. In people, changes in the same gene cause X-linked myotubular myopathy. That makes affected dogs a naturally-occurring model of the human disease, and it is part of why studying dogs moves medicine forward for everyone. It does not mean your dog has the human disease. It means the two share an underlying biology.
In people, the disease is described as: A rare X-linked congenital myopathy characterized by numerous centrally placed nuclei on muscle biopsy and that presents at birth with marked weakness, hypotonia and respiratory failure.
In humans it is also called: CNMX, MTM, XLCNM, XLMTM, centronuclear myopathy, X-linked.
Mapped from OMIA via the human disease's OMIM entry to the Mondo Disease Ontology (Monarch Initiative, CC-BY 4.0). Sniff renders this as a model-of link; the canine disease remains the subject of this page.
From OMIA's curated record
Documented in OMIA (Online Mendelian Inheritance in Animals). This describes the disease as recorded in the published literature, not a prediction for any individual dog. As of 2026-06-03.
Summary
Molecular genetics
Inheritance
Human analog
OMIA links this condition to its human counterpart in OMIM (Mendelian Inheritance in Man), the place to read across to the deeper human literature for the same biology.
Source: OMIA (Nicholas, Tammen & the Sydney Informatics Hub), entry OMIA:001508-9615, doi:10.25910/2AMR-PV70 (CC-BY 4.0).
How it presents
Catalogued in the Mondo disease ontology (the cross-species disease identity used by the Monarch Initiative) as X-linked centronuclear myopathy (MONDO:0010683).
Phenotype terms: Human Phenotype Ontology + Mammalian Phenotype Ontology; disease terms: Mondo (Monarch Initiative). Cross-references curated by OMIA (doi:10.25910/2AMR-PV70, CC-BY 4.0).
Published references
The peer-reviewed papers behind this disease, curated by OMIA. Starred entries are OMIA-designated landmark papers. Showing 6 of 13.
- Myosin inhibition partially rescues the myofibre proteome in X-linked myotubular myopathy. · JCI Insight · 2025 · PMID 41196692
- rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy. · Acta Neuropathol Commun · 2020 · PMID 33076971
- A mutation in MTM1 causes X-Linked myotubular myopathy in Boykin spaniels. · Neuromuscul Disord · 2020 · PMID 32417001
- Systemic AAV8-mediated gene therapy drives whole-body correction of myotubular myopathy in dogs. · Mol Ther · 2017 · PMID 28237839
- Long-term effects of systemic gene therapy in a canine model of myotubular myopathy. · Muscle Nerve · 2017 · PMID 28370029
- Long-term effects of systemic gene therapy on gait in a canine model of myotubular myopathy. · Muscle Nerve · 2017 · PMID 28470668
References curated by OMIA (Nicholas, Tammen & the Sydney Informatics Hub), doi:10.25910/2AMR-PV70 (CC-BY 4.0). Full list at the OMIA entry.
See what Myotubular Myopathy (Discovered in the Rottweiler) looks like in your dog's breed.
Observed only in small-sample breeds
Maximum variant frequency per breed across variants in the Donner 2023 cohort, with Wilson 95% confidence intervalsWilson 95% confidence intervalWhat it isThe range the true frequency is probably in. A wide range means we are less sure, usually because few dogs were tested.For your dogTrust tight ranges; treat wide ones as rough estimates.PreciselyA binomial-proportion confidence interval (Wilson score, 95%) that stays reliable at small sample sizes.Sniff Atlas methodology · statistical. The list below is split into well-sampled breeds (n ≥ 50 tested) and small-sample breeds (n < 50, where the Wilson CI typically spans more than 20 percentage points and frequencies should not be compared directly to the well-sampled entries). Frequencies are population-level, not per-litter or per-line.
Scope
This record carries the breed-level carrier frequencies from the Donner 2023 cohort. Penetrance data (the fraction of at-risk dogs that develop the phenotype) is not yet quantified for this disease in the Sniff Atlas v1.0.1. The OMIA entry is the authoritative reference for the clinical phenotype, inheritance pattern, and gene assignment.
Predicted disease relevance at the per-dog level is UNPROVEN. The variant frequency is measured; phenotype outcome depends on penetrance, environment, and modifier loci. Consult a veterinarian for clinical interpretation.
Citations
If you use this record in published work, cite the Sniff Atlas (the published dataset that carries the breed-level carrier frequencies) and the upstream sources:
- Sniff Atlas v1.0.1 for the per-breed carrier frequencies:
Gehring, M. (2026). Sniff Atlas v1.0.1. Zenodo. https://doi.org/10.5281/zenodo.20566358. CC-BY 4.0.
- OMIA for the disease definition, inheritance, and gene assignment:
Nicholas, F. W., & Tammen, I. (2024). OMIA. Sydney Informatics Hub, The University of Sydney. https://doi.org/10.25910/2AMR-PV70. Entry: OMIA:001508-9615.
- Donner et al. 2023 for the breed × variant carrier-frequency cohort:
Donner, J., Freyer, J., Davison, S., Anderson, H., Blades, M., Honkanen, L., et al. (2023). Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics, 19(2), e1010651. https://doi.org/10.1371/journal.pgen.1010651.
Full citation formats (BibTeX, RIS, CITATION.cff) at sniff.world/cite.
Related
- Gene page: MTM1, cited identity, disease associations, and the human-gene bridge.
- Sniff Atlas v1.0.1, the source dataset for these frequencies.
- Browse breeds, per-breed Mendelian profiles, including this disease in context.
- OMIA entry OMIA:001508-9615, authoritative clinical reference.
- About OMIA, the catalogue this record comes from, and how Sniff uses it.